Novartis AG is 180.6x more valuable than Syndax Pharmaceuticals Inc by market capitalization ($292.08 B vs $1.62 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SNDX | NVS |
|---|---|---|
| Market cap | $1.62 B | $292.08 B |
| US-listed rank | #2282 | #47 |
| Revenue (latest FY) | $172.35M | - |
| Net income (latest FY) | -$285.40M | - |
| Net margin | -165.6% | - |
| SEC filings | 636 | 947 |
Novartis AG is 180.6x more valuable than Syndax Pharmaceuticals Inc by market capitalization ($292.08 B vs $1.62 B).
Full pages: Syndax Pharmaceuticals Inc and Novartis AG, or browse the full rankings.